Skip to search formSkip to main contentSkip to account menu

TRC105

Known as: Anti-Endoglin Chimeric Monoclonal Antibody TRC105 
A human/murine chimeric monoclonal antibody directed against endoglin (CD105) with potential antiangiogenic and antineoplastic activities. Anti… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Endoglin, a TGF-b coreceptor predominantly expressed in endothelial cells, plays an important role in vascular development and… 
2017
2017
TRC105, a monoclonal antibody against endoglin, failed to improve progression-free survival when added to bevacizumab compared… 
2016
2016
The FDA has granted orphan drug designation for the novel agent known as TRC105, in development by Tracon Pharmaceuticals, for… 
2016
2016
Introduction: CD105 is involved in normal vascular development. It is over expressed on the surface of proliferating vascular… 
2013
2013
Magister en Ciencias de la Informacion y las Comunicaciones – Universidad Distrital “Francisco Jose de Caldas”, Ingeniero… 
2012
2012
The CD105 antigen (endoglin) is a hypoxia-inducible, 180-kDa, disulfide-linked, homodimeric transmembrane glycoprotein that is a… 
2012
2012
  • 2012
  • Corpus ID: 34499795
ID: 17654 Title: In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nano-Graphene Purpose…